Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Procedure
  • Participants: 56
  • Start Date: March 5, 2021
Pilot Study of Oral Cryotherapy vs. Oral Cryotherapy Plus Acupuncture and Acupressure to Decrease Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy for GI Cancers
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Procedure, Drug
  • Participants: 36
  • Start Date: December 29, 2020
A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 500
  • Start Date: October 30, 2020
Genetic Testing for Breast, Ovarian, Pancreatic and Prostate Cancers - GeneBOPP
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Procedure, Other, Behavioral
  • Participants: 50
  • Start Date: September 14, 2020
Re-Defining Frailty and Improving Outcomes Through Prehabilitation (RIOT Trial)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 146
  • Start Date: July 17, 2020
Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Biological, Procedure, Other
  • Participants: 40
  • Start Date: April 1, 2020
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Trial: PRIME
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Biological
  • Participants: 40
  • Start Date: February 20, 2020
Clinical Study of CEA-Targeted CAR-T Therapy in Patients With Relapsed and Refractory CEA+ Cancer
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Radiation, Procedure
  • Participants: 30
  • Start Date: November 5, 2019
PET Biodistribution Study of 68Ga-PSMA-11 and 68Ga-FAPI-46 in Patients With Non-Prostate Cancers: An Exploratory Biodistribution Study With Histopathology Validation
Showing 1-12 of 38